Oncology & Hematology Coding Alert

READER QUESTIONS:

Use J9999 for Temozolomide for Now

Question: What J code should I report for intravenous temozolomide?

New Jersey Subscriber

Answer: HCPCS doesn't currently offer a specific code for temozolomide, so you should report J9999 (Not otherwise classified, antineoplastic drugs).

Stay tuned: Temozolomide, sold as Temodar, had a spot in the April 2009 HCPCS Public Meeting agenda (www.cms.hhs.gov/MedHCPCSGenInfo/Downloads/DrugBiologicalsandRadiopharmaceuticals-Agenda.pdf).

CMS's preliminary decision was to create a J code for "Injection, Temozolomide, 1mg."

Who needs it: Oncologists use temozolomide for adult patients with glioblastoma multiforme (coded as a malignant neoplasm based on site) and refractory anaplastic astrocytoma (also coded as malignant neoplasm by site).

Other Articles in this issue of

Oncology & Hematology Coding Alert

View All